- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00634335
Echocardiographic Characteristics of High Endurance Israeli Athletes
Study Overview
Status
Conditions
Detailed Description
Adaptive cardiac changes, such as enlargement of left ventricle mass and enlargement of left ventricular wall was observed in athletes. The physiological limit of remodeling changes in accordance to sex, type of activity, intensity of activity, genetics and race.
Although many studies were conducted on this subject, it is still impossible to predict if an athlete from a certain sport will develop cardiac changes and their what will those changes characteristics will be.
Sudden cardiac death is the leading cause of death among young athletes, this is because of high physical activity in the presence of a hidden heart disease, therefore there is much debate about the needed screening tests for athletes.
In Israel, there is only one study in this subject that showed no significant cardiac changes in Olympic athletes of various types of sports. the study didn't focused on high endurance sport athletes such as professional bicyclists although cardiac endurance is a main factor in cardiac changes.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Sergio Kobal, MD
- Phone Number: 972-8-6400133
- Email: kobal@bgu.ac.il
Study Locations
-
-
-
Beer-Sheva, Israel
- Recruiting
- Soroka University Medical Center
-
Contact:
- KOBAL SERGIO, MD
- Phone Number: 972-8-6400133
- Email: kobal@bgu.ac.il
-
Principal Investigator:
- SERGIO KOBAL, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Known athletes of the bicyclists organization of Israel or any other known organization for 2 year at least.
- Participated in at least one contest recognized by the bicyclists organization of Israel.
- Had been in training for the last 3 months at least, which included minimum of 8 hours a week in average
Exclusion Criteria:
- Do not suffer any known cardiac disease
- Had declared that they are not using drugs which are forbidden by the Olympic committee
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
sk
professional Israeli bicyclists
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sergio Kobal, MD, Soroka medical center, Israel
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- sor465808ctil
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Athlete's Heart
-
University of AlbertaCompletedAthlete's ShoulderCanada
-
Peking University Third HospitalCompleted
-
AmDermaCompleted
-
Merz North America, Inc.CompletedTinea Pedis | Athlete's FootUnited States
-
AmDermaAmDerma Pharmaceuticals, LLCCompletedTinea Pedis | Athlete's FootUnited States
-
AmDermaAmDerma Pharmaceuticals, LLCCompletedTinea Pedis | Athlete's FootUnited States
-
mustafa gulsenOkan UniversityCompleted
-
Investigación en Hemofilia y FisioterapiaWithdrawn
-
Universitas Muhammadiyah SemarangCompleted
-
Jamaica Hospital Medical CenterJohnson & JohnsonUnknownTinea Pedis | Athlete's Foot | Foot Fungus | RingwormUnited States